Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): The challenge of a new consensus conference;Prise en charge des infections des voies respiratoires basses de l'adulte immunocompétent (pneumonie aiguë communautaire, exacerbation de bronchopathie chronique obstructive) : les enjeux d'une nouvelle conférence de consensus

Medecine et Maladies Infectieuses

Volumn 36, Issue 11-12, 2006, Pages 535-537

  Chidiac, C ^a  

^a CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM; ERTAPENEM; GATIFLOXACINE; GEMIFLOXACINE; GREPAFLOXACINE; LINEZOLID; MACROLIDE; PRISTINAMYCIN; QUINOLONE; SPARFLOXACINE; TELITHROMYCIN; TEMAFLOXACIN; TROVAFLOXACINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE EXACERBATION; EDITORIAL; HEART DISEASE; HUMAN; IMMUNOCOMPETENCE; LOWER RESPIRATORY TRACT INFECTION; MEDICAL RESEARCH; NONHUMAN; TENDON DISEASE; COMMUNICABLE DISEASE; DRUG COMBINATION; IMMUNOLOGY; PATHOPHYSIOLOGY; PNEUMONIA; RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; HUMANS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS;

EID: 33845226269     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2006.10.002     Document Type: Editorial

References (22)

1. SPILF. Première conférence de consensus en thérapeutique anti-infectieuse : la pneumocystose au cours de l'infection a VIH. Med. Mal. Inf. 20 Suppl 2 (1990) 314-317
2. e conférence de consensus en thérapeutique anti-infectieuse : les infections des voies respiratoires 18 octobre 1991. Lille Med. Mal. Inf. 22 Suppl 2 (1992) 43-46
3. Mouton Y., Bignolas G., Chidiac C., Decazes J.M., Gehanno P., and groupe de travail. Recommandations sur la prise en charge de la pathologie infectieuse respiratoire. Med. Mal. Inf. 25 (1995) 1021-1028
4. e conférence de consensus en thérapeutique anti-infectieuse de la Société de pathologie infectieuse de langue française (SPILF). Med. Mal. Inf. 31 (2001) 265-266
5. Afssaps. Antibiothérapie par voie générale en pratique courante : infections respiratoires basses de l'adulte. Med. Mal. Inf. 32 (2002) 125-126
6. Afssaps. Antibiothérapie par voie générale en pratique courante, infections respiratoires basses de l'adulte et de l'enfant (actualisation novembre 2005). http://afssaps.sante.fr/htm/5/rbp/indantib.htm.
7. ANAES. Guide d'analyse de la littérature et gradation des recommandations. Janvier 2000 ; http://www.anaes.fr/anaes/anaesparametrage.nsf/Page?ReadForm&Section=/anaes/anaesparametrage.nsf/accueilevaluation?readform&Defaut=y&.
8. HAS. Grille d'évaluation de la qualité des recommandations pour la pratique clinique. Traduction française de la grille AGREE (appraisal of guidelines for research and evaluation instrument) : http://www.anaes.fr/anaes/anaesparametrage.nsf/Page?ReadForm&Section=/anaes/anaesparametrage.nsf/accueilevaluation?readform&Defaut=y&.
9. Bartlett J.G., Dowell S.F., Mandell L.A., File T.M., Musher D.M., and Fine M.J. Practice guidelines for the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 31 (2000) 347-382
10. Mandell L.A., Bartlett J.G., Dowell, File T.M., Musher D.M., and Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. 37 (2003) 1405-1433
11. Mandell L.A., Marrie T.J., Grossman R.F., Chow A.W., and Hyland R.H. Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can. Respir. J. 5 (2000) 371-382
12. Niederman M.S., Mandell L.A., Anzueto A., Bass J.B., Broughton W.A., Campbell G.D., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 163 (2001) 1730-1754
13. Chidiac C. De la résistance à l'échec clinique : quelle réalité? Pneumonies communautaires. In: Gehanno P., Léophonte P., and Mouton Y. (Eds). Infections respiratoires : les résistances bactériennes en pratique clinique (2001), EDK ed., Paris 67-79
14. Chidiac C. Nouvelles fluoroquinolones et pneumonies aiguës communautaires (PAC). La Lettre de l'Infectiologue 17 (2002) 95-98
15. Afssaps. Indications et alternatives thérapeutiques aux fluoroquinolones. http://afssaps.sante.fr/htm/10/biotox/fluoroq.pdf.
16. Gutierrez F., Masia M., Rodriguez J.C., Mirete C., Soldan B., Padilla S., et al. Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome. Eur. J. Clin. Microbiol. Infect. Dis. 24 (2005) 377-383
17. Martinez J.A., Horcajada J.P., Almela M., Marco F., Soriano A., Garcia E., et al. Addition of a macrolide to a betalactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 36 (2003) 389-395
18. Epstein B.J., and Gums J.G. Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapy. Drugs 65 (2005) 1949-1971
19. Weiss K., Low D.E., Cortes L., Beaupre A., Gauthier R., Gregoire P., et al. Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults. Can. Respir. J. 11 (2004) 589-593
20. Stralin K., Sjoberg L., and Holmberg H. Short-course betalactam treatment for community-acquired pneumonia. Clin. Infect. Dis. 38 5 (2004) 766-767
21. Mandell L.A., and File Jr. T.M. Short-course treatment of community-acquired pneumonia. Clin. Infect. Dis. 37 6 (2003) 761-763
22. Dunbar L.M., Wunderink R.G., Habib M.P., Smith L.G., Tennenberg A.M., Khashab M.M., et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis. 37 6 (2003) 752-760 (Erratum in. Clin. Infect. Dis. 2003;37(8):1147)